Kisqali 400 MG daily dose 42S
Ended Awarded
- Contract number
- SPE2DB25FXL82
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $73,222
Award facts
- Contract value 100% obligated
- $73,222.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Kisqali 400 mg daily dose tablets (42-count packaging) valued at $73,222.38. The contract, executed on September 22, 2025, with an ultimate completion date of September 23, 2025, utilizes firm fixed-price terms and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. Kisqali is a brand-name oncology medication used in cancer treatment, consistent with AmerisourceBergen's established role as a critical pharmaceutical supplier for federal medical procurement.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to compete successfully for federal pharmaceutical contracts, combined with its significant prime vendor relationship with DLA, positions the company as a key supplier for Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FXL82?
SPE2DB25FXL82 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FXL82 worth?
The government has obligated $73,222 on SPE2DB25FXL82.
Is contract SPE2DB25FXL82 an order under another contract?
Yes. SPE2DB25FXL82 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXL82 competed?
The extent of competition for SPE2DB25FXL82 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award